Biomarkers and brain stimulation for treatment-resistant depression
Part of Mental health clinical trials.
This study looks at whether certain substances in the blood can help predict how well a type of brain stimulation called intermittent theta burst stimulation (iTBS) works for people whose depression hasn't improved with standard treatments. It may help doctors choose better treatments in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age between 18 and 55 years old.
- Diagnosed with major depression that hasn't gotten better with at least two different antidepressants.
- Able to undergo transcranial magnetic stimulation (TMS) treatment.
- Can attend study visits and complete thinking and memory tests.
- No other major psychiatric conditions like bipolar disorder or schizophrenia.
- No history of seizures, brain tumors, severe head injury, or other serious brain conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an accelerated form of iTBS (a non-invasive brain stimulation technique) for depression that hasn't improved with antidepressant medications. The goal is to help people with major depression who haven't responded adequately to at least one antidepressant drug.
This study tests a type of brain stimulation called cTBS (continuous theta burst stimulation) applied to a specific part of the brain (the precuneus) to see if it helps with treatment-resistant depression. It aims to provide a new option for people who haven't found relief from standard treatments.
This trial tests a personalized brain stimulation method called neuronavigated aiTBS for people with depression that hasn't improved with at least two prior treatments. The goal is to see if this therapy can safely and effectively reduce depressive symptoms.
This study compares two fast types of brain stimulation (called accelerated theta burst stimulation) to see which works better for people whose depression hasn't improved with standard antidepressants. It's designed for people with treatment-resistant depression who are already on a stable antidepressant.
This study tests a type of brain stimulation called TMS (transcranial magnetic stimulation) for people with depression that hasn't improved with at least two antidepressants. Researchers want to see if a faster version of TMS (theta-burst stimulation) helps reduce depression symptoms.
This study tests how a specific kind of brain stimulation (repetitive transcranial magnetic stimulation) works for people with depression that has not responded to standard treatments. If you qualify, it may help doctors understand the mechanism and improve options for treatment-resistant depression.
Hear when a new Major Depression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.